Vectivbio Holding Stock Price, News & Analysis
Company Description
Vectivbio Holding (NASDAQ: VECT) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.1B.
VECT stock has declined 100.0% over the past year.
This page provides a comprehensive overview of VECT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vectivbio Holding (VECT) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.1B, VECT is classified as a small-cap stock with approximately 62.8M shares outstanding.
Latest News
Vectivbio Holding has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management, acquisition, earnings, conferences, clinical trial. View all VECT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
VECT Company Profile & Sector Positioning
Vectivbio Holding (VECT) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.